I am a Healthcare Professional outside the US and UK

I am a Healthcare Professional outside the US and UK

Click here for international medical scientific information about Oncology for Healthcare Professionals.

I am not a Healthcare Professional and I am outside the US and the UK

I am not a Healthcare Professional and I am outside the US and the UK

Click here for general international information for patients, caregivers and the general public.

Country-specific medical scientific information

Country-specific medical scientific information

Country-specific medical scientific information for Healthcare Professionals.

This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

InOncology.com

ASCO, CHICAGO, IL, USA, 31 May-4 JUNE 2019

Targeting IGF-1/2 with xentuzumab plus enzalutamide in metastatic castration-resistant prostate cancer after progression on docetaxel chemotherapy and abiraterone: Randomized phase II trial results

Syed Hussain, José Pablo Maroto, Miguel Ángel Climent, Diletta Bianchini, Robert Hugh Jones,  Chia-Chi Lin, Shian-Shiang Wang, Emma Dean, Kate Crossley, Laura Schlieker, Thomas Bogenrieder, Johann de Bono

FOR HEALTHCARE PROFESSIONALS ONLY.

 

image